Literature DB >> 34170199

Multimodal Bone Metastasis-associated Epidermal Growth Factor Receptor Imaging in an Orthotopic Rat Model.

Tobias Bäuerle1, Suresh Gupta1, Shaokuan Zheng1, Lisa Seyler1, Anita Leporati1, Miklos Marosfoi1, Simone Maschauer1, Olaf Prante1, Peter Caravan1, Alexei Bogdanov1.   

Abstract

Purpose To develop multimodality imaging techniques for measuring epidermal growth factor receptor (EGFR) as a therapy-relevant and metastasis-associated molecular marker in triple-negative mammary adenocarcinoma metastases. Materials and Methods An orthotopic bone metastasis EGFR-positive, triple-negative breast cancer (TNBC) model in rats was used for bioluminescence imaging, SPECT/CT, PET/CT, and MRI with quantitative analysis of transcripts (n = 22 rats). Receptor-specific MRI of EGFR expression in vivo was performed by acquiring spin-echo T1-weighted images after sequential administration of a pair of anti-EGFR antigen binding fragments, F(ab')2, conjugated to either horseradish peroxidase or glucose oxidase, which have complementing activities, as well as paramagnetic (gadolinium[III]-mono-5-hydroxytryptamide of 2,2',2''-(10-(2,6-dioxotetrahydro-2H-pyran-3-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid, or Gd-5HT-DOTAGA) or positron-emitting (gallium 68-5HT-DOTAGA) substrates for MRI and PET/CT imaging, respectively. EGFR expression was confirmed by quantitative reverse transcriptase polymerase chain reaction and immunohistochemical analyses to compare with image findings. Results After surgical intraarterial delivery of TNBC cells, rats developed tumors that diverged into either rapidly growing osteolytic or slow-growing nonosteolytic tumors. Both tumor types showed receptor-specific initial MRI signal enhancement (contrast-to-noise ratio) that was three to six times higher than that of normal bone marrow (29.4 vs 4.9; P < .01). Micro PET/CT imaging of EGFR expression demonstrated a high level of heterogeneity with regional uptake of the tracer, which corresponded to region-of-interest MRI signal intensity elevation (121.1 vs 93.3; P < .001). Analysis of metastases with corroboration of imaging results showed high levels of EGFR protein and messenger RNA, or mRNA, expression in the invasive tumor. Conclusion Convergence of multimodal molecular receptor imaging enabled comprehensive assessment of EGFR overexpression in an orthotopic model of TNBC metastasis. Keywords: Animal Studies, Molecular Imaging-Cancer, MR-Contrast Agent, Radionuclide Studies, Skeletal-Appendicular, Metastases Supplemental material is available for this article. © RSNA, 2021.

Entities:  

Keywords:  Animal Studies; MR-Contrast Agent; Metastases; Molecular Imaging-Cancer; Radionuclide Studies; Skeletal-Appendicular

Mesh:

Substances:

Year:  2021        PMID: 34170199      PMCID: PMC8344354          DOI: 10.1148/rycan.2021200069

Source DB:  PubMed          Journal:  Radiol Imaging Cancer        ISSN: 2638-616X


  59 in total

1.  Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies.

Authors:  Vojtech Kubícek; Jana Havlícková; Jan Kotek; Gyula Tircsó; Petr Hermann; Eva Tóth; Ivan Lukes
Journal:  Inorg Chem       Date:  2010-11-03       Impact factor: 5.165

2.  Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs.

Authors:  M Christofidou-Solomidou; G G Pietra; C C Solomides; E Arguiris; D Harshaw; G A Fitzgerald; S M Albelda; V R Muzykantov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-04       Impact factor: 5.464

3.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

4.  Quantitative in vivo immunohistochemistry of epidermal growth factor receptor using a receptor concentration imaging approach.

Authors:  Kimberley S Samkoe; Kenneth M Tichauer; Jason R Gunn; Wendy A Wells; Tayyaba Hasan; Brian W Pogue
Journal:  Cancer Res       Date:  2014-10-24       Impact factor: 12.701

Review 5.  Triple-negative breast carcinoma: current and emerging concepts.

Authors:  Robert Schmadeka; Bryan E Harmon; Meenakshi Singh
Journal:  Am J Clin Pathol       Date:  2014-04       Impact factor: 2.493

6.  Transactivation of vimentin by beta-catenin in human breast cancer cells.

Authors:  Christine Gilles; Myriam Polette; Mélanie Mestdagt; Béatrice Nawrocki-Raby; Philippe Ruggeri; Philippe Birembaut; Jean-Michel Foidart
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

7.  Preclinical safety studies of glucose oxidase.

Authors:  M Samoszuk; D Ehrlich; E Ramzi
Journal:  J Pharmacol Exp Ther       Date:  1993-09       Impact factor: 4.030

8.  Modular strategy for the construction of radiometalated antibodies for positron emission tomography based on inverse electron demand Diels-Alder click chemistry.

Authors:  Brian M Zeglis; Priya Mohindra; Gabriel I Weissmann; Vadim Divilov; Scott A Hilderbrand; Ralph Weissleder; Jason S Lewis
Journal:  Bioconjug Chem       Date:  2011-09-20       Impact factor: 4.774

9.  Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination.

Authors:  Adher D Al Sayed; Mahmoud A Elshenawy; Asma Tulbah; Taher Al-Tweigeri; Hazem Ghebeh
Journal:  Am J Case Rep       Date:  2019-11-06

10.  Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.

Authors:  Ana Luiza Ribeiro de Souza; Kayla Marra; Jason Gunn; Kimberley S Samkoe; P Jack Hoopes; Joachim Feldwisch; Keith D Paulsen; Brian W Pogue
Journal:  Mol Imaging Biol       Date:  2017-02       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.